检索结果-南通市图书馆

Guidelines for the Diagnosis and Treatment of Dengue in china

Infectious Diseases & Immunity 2021年第3期1卷 144-152页

作者： Fuchun Zhang Jianfeng He Jie Peng Xiaoping Tang Chengfeng Qin Hongzhou Lu Xingwang Li Qingquan Liu Hong Zhao Jifang Sheng Guiqiang Wang Society of Infectious Diseases,Society of Tropical Medicine and Parasitology,Chinese Medical Association Society of Emergency Medicine,china Association of Chinese Medicine Department of Infectious Diseases Guangzhou Eighth People’s HospitalGuangzhou Medical UniversityGuangzhou 510060China Guangdong Provincial center for Disease Control and Prevention Guangzhou 511430China Department of Infectious Diseases Nanfang HospitalSouthern Medical UniversityGuangzhou 510515China Department of Virology State Key Laboratory of Pathogen and BiosecurityBeijing Institute of Microbiology and EpidemiologyAcademy of Military Medical SciencesBeijing 100071China Shanghai Public health Clinical center Shanghai 201508China Department of Infectious Diseases Beijing Ditan HospitalCapital Medical UniversityBeijing 100015China beijing Hospital of Traditional Chinese Medical Beijing 100010China Department of Infectious Diseases Center for Liver DiseasesPeking University First HospitalBeijing 100034China Department of Infectious Diseases The First Affiliated HospitalCollege of MedicineZhejiang UniversityHangzhou 310003China. 不详

Dengue is the most prevalent and rapidly spreading mosquito-borne viral *** a dengue non-endemic country,china has experienced several dengue outbreaks in recent ***,dengue patients in china display clinical characteristics that are distinct from those of patients in dengue-endemic *** standardize the diagnosis and treatment of dengue fever,the experts at the Society of Infectious Diseases,Society of Tropical Medicine and Parasitology of the Chinese Medical Association,and the Society of Emergency Medicine of china Association of Chinese Medicine have developed a guideline after reviewing the following guidelines and data:guidelines for diagnosis,treatment,prevention,and control of dengue(World {3. Organization,2009);the guidelines for diagnosis and treatment of dengue(National {3. and Family Planning Commission of the People’s Republic of china,2014,Edition 2);{3. industry standard of the People’s Republic of china“diagnosis for dengue fever(WS216-2018)”;and systemic reports on *** new guideline includes eight aspects:introduction,terminology,epidemiology and prevention,etiology and pathogenesis,clinical features,diagnosis,treatment,and problems to be solved.

关键词： Dengue Diagnosis Treatment Guideline

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Unsatisfying antiviral therapeutic effect in patients with mother-tochild transmissed chronic hepatitis B virus infection: a prospective multi-center clinical study

引用

Chinese Medical Journal 2019年第22期132卷 2647-2656页

作者： Jun Li Xiao-Qin Dong Zhao Wu An-Lin Ma Shi-Bin Xie Xu-Qing Zhang Zhan-Qing Zhang Da-Zhi Zhang Wei-Feng Zhao Guo Zhang Jun Cheng Qing Xie Jun Li Zhi-Qiang Zou Ying-Xia Liu Gui-Qiang Wang Hong Zhao china Hepatitis B Related Fibrosis Assessment Research Group Department of Infectious Diseases Center for Liver DiseasePeking University First HospitalBeijing 100034China Department of Infectious Diseases Tongji Hospital of Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanHubei 430030China Department of Infectious Diseases China-Japan Friendship HospitalBeijing 100029China Department of Infectious Diseases The Third Affiliated Hospital Sun Yat-Sen UniversityGuangzhouGuangdong 510000China Department of Infectious Diseases South West Hospital Affiliated to Third Military Medical UniversityChongqing 400038China Department of Hepatology Shanghai Public Health Clinical CenterFudan UniversityShanghai 200083China Department of Infectious Diseases Second Affiliated Hospital of Chongqing Medical UniversityChongqing 404000China Department of Infectious Diseases Xinxiang Medical University Third HospitalXinxiangHenan 453003China Department of Infectious Diseases The People's Hospital of Guangxi Zhuang Autonomous RegionNanningGuangxi 530021China Department of Infectious Diseases Di Tan Hospital Affiliated to Capital Medical UniversityBeijing 100015China Department of Infectious Diseases Rui Jin HospitalShanghai Jiao Tong University School of MedicineShanghai 200090China Department of Infectious Diseases The First Affiliated Hospital of Nanjing Medical UniversityNanjingJiangsu 211166China Department of Infectious Diseases Yantai City Hospital for Infectious DiseaseYantaiShandong 264001China Shenzhen Key Laboratory of Pathogen and Immunity State Key Discipline of Infectious DiseaseShenzhen Third People's HospitalShenzhenGuangdong 518034China The Collaborative Innovation center for Diagnosis and Treatment of Infectious Diseases Zhejiang UniversityHangzhouZhejiang 310085China Department of Infectious Diseases Peking University International HospitalBeijing 102206China 不详

Background:Few data are available regarding the progression of liver disease and therapeutic efficacy in chronic hepatitis B(HBV)carriers infected by mother-to-child transmission(MTCT).This study aimed to investigate these two aspects by comparing the adult chronic HBV carriers in MTCT group with those in horizontal transmission ***:The 683.adult chronic HBV patients qualified for liver biopsy including 191 with MTCT and 492 with horizontal transmission entered the multi-center prospective study from October 2013.to May *** results from 217 patients at baseline and 78 weeks post antiviral therapy were ***:Patients infected by MTCT were more likely to have e antigen positive(68.6%vs.58.2%,x^2=-2.491,P=0.012)than those with horizontal ***,in patients with MTCT,levels of alkaline phosphatase(ALP)(P=0.03.),Fibroscan(P=0.013.,N-terminal propeptide of Type III procollagen(PIIINP)(P=0.014),and Laminin(LN)(P=0.006)were high,in contrast to the patients with horizontal transmission for whom the levels of albumin(ALB)(P=0.041),matrix metalloproteinase-3.MMP-3.(P=0.001)were *** 47.2% of patients with MTCT and 3..8%of those with horizontal transmission had significant liver fibrosis(P=0.013..Following antiviral therapy for 78 weeks,21.2%and 3..0%patients with MTCT and horizontal transmission acquired hepatitis B e antigen(HBeAg)clearance,respectively(P=0.043.,and the virological response rates were 54.7%and 74.1%in the MTCT and horizontal groups,respectively(P=0.005).MTCT was a risk factor for HBeAg clearance and virological ***:Adult patients with MTCT were more prone to severe liver diseases,and the therapeutic efficacy was relatively poor,which underlined the importance of earlier,long-term treatment and interrupting perinatal transmission.

关键词： Chronic Hepatitis B virus infection Horizontal transmission Mother-to-child transmission Progression of disease Therapeutic efficacy

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

我国北方人群24 h尿钠排泄量与全因死亡的相关性分析

引用

中华心血管病杂志 2022年第12期50卷 1220-1228页

作者：刘小云刘之光邓卿成小如胡泊刘力生王兴河首都医科大学附属北京世纪坛医院药物Ⅰ期临床试验研究室北京100038 首都医科大学附属北京安贞医院药事部北京100029 中国医学科学院北京协和医学院国家心血管病中心阜外医院医学统计部北京102300 北京高血压联盟研究所北京100039

目的探讨我国北方人群24 h尿钠排泄量(24hUNaE)与全因死亡风险的关系。方法本研究基于前瞻性城乡流行病学研究中国队列的随访调查,纳入我国北方人群数据。由经过培训的研究人员采用面对面形式记录所有参与者的基线信息,并收集其清晨空... 详细信息

目的探讨我国北方人群24 h尿钠排泄量(24hUNaE)与全因死亡风险的关系。方法本研究基于前瞻性城乡流行病学研究中国队列的随访调查,纳入我国北方人群数据。由经过培训的研究人员采用面对面形式记录所有参与者的基线信息,并收集其清晨空腹尿标本,估算24hUNaE和24 h尿钾排泄量(24hUKE)以衡量钠、钾摄入量。采用多元脆弱Cox回归模型分析24hUNaE(3.00、3.00~3.99、4.00~4.99、5.00~5.99和≥6.00 g/d)与全因死亡的关系。结果本研究共纳入273.0名研究对象。24hUNaE为(5.84±1.73.g/d。中位随访时间8.8年,全因死亡共发生1024例(3.7%),其中心血管相关死亡3.0例,非心血管相关死亡591例,其余患者死亡原因无法确定。以24hUNaE 4.00~4.99 g/d为参照组,校正其他影响因素后,当24hUNaE≥6 g/d时全因死亡(HR=1.24,95%CI:1.02~1.49)和心血管相关死亡(HR=1.3.,95%CI:1.02~1.88)的发生风险显著增加;当24hUNaE3.00 g/d时,全因死亡的发生风险增加(HR=1.3.,95%CI:0.96~1.99),但无显著相关性。24hUNaE与非心血管相关死亡的发生风险无显著相关性。以24hUNaE 4.00~4.99 g/d伴24hUKE≥2.11 g/d为参照组,全因死亡和心血管相关死亡的发生风险在低尿钠(24hUNaE3.00 g/d)伴低尿钾(24hUKE3.g/d)或过高(≥6 g/d)与全因死亡和心血管相关死亡风险增加有关。适度的钠摄入同时增加钾摄入可能对机体健康更有益。

关键词：钠钾尿液全因死亡心血管相关死亡

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

儿童糖原累积病Ⅱ型诊断及治疗中国专家共识

引用

中华儿科杂志 2021年第6期59卷 439-445页

作者：中华医学会儿科学分会内分泌遗传代谢学组中华医学会医学遗传学分会中华医学会儿科学分会罕见病学组北京医学会医学遗传学分会北京罕见病诊疗与保障学会中国罕见病联盟邱正庆罗小平傅君芬不详中国医学科学院北京协和医学院北京协和医院儿科 100730 华中科技大学同济医学院附属同济医院儿科学系武汉430030 浙江大学医学院附属儿童医院内分泌科国家儿童健康与疾病临床研究中心杭州310051

糖原累积病Ⅱ型是目前所知唯一属于溶酶体贮积症的糖原累积病。糖原累积病Ⅱ型患儿发病年龄不同,症状复杂,早诊断早治疗才能更好地控制病情。为了规范儿童糖原累积病Ⅱ型的诊断和治疗,中华医学会儿科学分会内分泌遗传代谢学组组织相关... 详细信息

糖原累积病Ⅱ型是目前所知唯一属于溶酶体贮积症的糖原累积病。糖原累积病Ⅱ型患儿发病年龄不同,症状复杂,早诊断早治疗才能更好地控制病情。为了规范儿童糖原累积病Ⅱ型的诊断和治疗,中华医学会儿科学分会内分泌遗传代谢学组组织相关专家在2013.专家共识的基础上,结合近10年来国内外有关儿童糖原累积病Ⅱ型的最新诊治研究进展及相关中国专家的临床经验总结,制定了适合中国国情的儿童糖原累积病Ⅱ型诊治专家共识。

关键词：中华医学会发病年龄糖原累积病溶酶体贮积症专家共识儿科学分会诊治研究临床经验总结

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

中度主动脉瓣狭窄人群的预后及左室收缩功能在其中的预测价值:一项来自china-VHD队列的研究（英文）

引用

science Bulletin 2023年第22期 2717-2720+2668页

作者：刘先宝朱齐丰刘琼许海燕戴晗怡周瑶瑶陈俊 Stella Ng 鲁烨赵延延李喆吴永健王建安 china-VHD研究团队 Department of Cardiology The Second Affiliated Hospital Zhejiang University School of Medicine Department of Cardiology Fuwai Hospital National Center for Cardiovascular Disease Chinese Academy of Medical Science and Peking Union Medical College Department of Cardiology Affiliated Jinhua Hospital Zhejiang University School of Medicine Medical Research&Biometrics center Fuwai Hospital National Center for Cardiovascular Disease Chinese Academy of Medical Science and Peking Union Medical College

中度主动脉瓣狭窄(AS)患者的预后存在争议,尤其是左室收缩功能(LVEF)在该人群的应用价值仍不明确.该研究旨在探讨中度AS患者的预后及左室收缩功能对其的预测价值.研究通过全国多中心前瞻性队列研究china-VHD连续纳入了来自中国46家三甲...

中度主动脉瓣狭窄(AS)患者的预后存在争议,尤其是左室收缩功能(LVEF)在该人群的应用价值仍不明确.该研究旨在探讨中度AS患者的预后及左室收缩功能对其的预测价值.研究通过全国多中心前瞻性队列研究china-VHD连续纳入了来自中国46家三甲医院的万余名严重瓣膜病患者,其中513.为中度AS,并依据LVEF界值分为三组,分别为LVEF≤40%(LVEF显著降低组),40%3.0%为男性,平均年龄62.0岁.2年随访期内,中度AS患者生存率显著低于年龄和性别相匹配的中国人群的预期生存率(P 3.02,P=0.020;LVEF正常组为对照/参考),相对死亡风险随着LVEF的降低而呈单调增加趋势,LVEF的最佳界值为60%.研究结果提示,LVEF降低是中度AS人群预后不佳的首要危险因素,今后或可考虑将LVEF低于60%作为进一步干预的界值.

关键词：

来源：

同方期刊数据库评论

在线全文

同方期刊数据库

学校读者我要写书评

暂无评论

Digestive tract reconstruction in pancreaticoduodenectomy in university Hospitals of china: a national questionnaire survey

引用

Journal of Pancreatology 2022年第4期5卷 127-152页

作者： Jishu Wei Qiang Xu Yuhua Zhang Jiabin Jin Xiaodong Tian Qiaofei Liu Zipeng Lu Zheng Wang Shanmiao Gou Song Gao Xianlin Han Yefei Rong Niandong Ji Ye Lin Guolin Li Shi Chen Feng Cao Hua Chen Wenming Wu Yupei Zhao the Young Elite Pancreatic Surgery Club of china Pancreas center The First Affiliated Hospital of Nanjing Medical UniversityNanjing Department of General Surgery State Key Laboratory of Complex and Rare DiseasesPeking Union Medical College HospitalChinese Academy of Medical Science and Peking Union Medical CollegeBeijing Department of Hepatobiliary and Pancreatic Surgery The Cancer Hospital of the University of Chinese Academy of Sciences(Zhejiang Cancer Hospital)Institute of Basic Medicine and Cancer(IBMC)Chinese Academy of SciencesHangzhou Department of General Surgery Pancreatic Disease CenterRuijin HospitalShanghai Jiao Tong University School of MedicineShanghai Department of General Surgery Peking University First HospitalBeijing Department of Hepatobiliary Surgery the First Affiliated Hospital of Xi’an Jiaotong UniversityPancreas Center of Xi’an Jiaotong University Department of Pancreatic Surgery Union HospitalHuazhong University of Science and TechnologyWuhan Department of Pancreatic Carcinoma Tianjin Medical University Cancer Hospital and InstituteTianjin Department of pancreatic surgery Zhongshan HospitalFudan UniversityShanghai Department of General Surgery Xiangya HospitalCentral South UniversityChangsha Department of Hepatobiliary Surgery Guangdong Provincial People's HospitalGuangdong Academy of Medical SciencesGuangzhou Department of Hepatobiliary Pancreatic and Splenic Surgerythe Sixth Affiliated Hospital of Sun Yat-sen UniversityGuangzhou Department of Hepato-biliary-pancreatic Surgery Fujian Provincial HospitalFuzhou Department of General Surgery Xuanwu HospitalCapital Medical UniversityBeijing Department of Pancreatic and Biliary Surgery Harbin Medical UniversityHarbin 不详

Background Pancreaticoduodenectomy(PD)has been widely applied in general hospitals in china;however,there is still a lack of unified standards for each surgical technique and *** survey is intended to investigate the current status of digestive tract reconstruction after PD in university hospitals in *** A cross-sectional survey was conducted among the members of the Young Elite Pancreatic Surgery Club of china by using the Questionnaire for Digestive Tract Reconstruction after *** questionnaire was disseminated and collected by point-to-point communication via WeChat public *** A total of 73.valid questionnaires were returned from 65 university hospitals in 28 provincial divisions of china's *** respondents who performed PD surgery with an annual volume of over 100 cases accounted for 63..Generally,laparoscopic PD was performed less often than open *** and Whipple reconstructions accounted for 70%and 26%,*** sequence of pancreatoenteric,biliary-enteric,and gastrointestinal reconstruction accounted for 84%of *** pancreatoenteric anastomosis,double-layer anastomosis is the most commonly employed type,accounting for approximately 67%,while single-layer anastomosis accounts for 3.%.Of the double-layer anastomoses,duct-to-mucosa/dunking(94%/4%)PJ was performed with duct-mucosa using the Blumgart method(3.%)and Cattel-Warren(29%),with continuous/interrupted sutures in the inner layer(69%/3.%)and continuous/interrupted sutures in the outer layer(53./23.).In single-layer anastomosis,continuous/interrupted sutures accounted for 41%/45%.In hepatojejunostomy,single-layer/double-layer suture accounted for 79%/4%,and continuous/interrupted suture accounted for 75%/9%.Forty-six percent of the responding units had not applied double-layer biliary-intestinal anastomosis in the last 3.years,75%of the responding surgeons chose the anastomosis method according to bile duct diameter,with absorbab

关键词： Pancreaticoduodenectomy Digestive tract reconstruction university hospitals Questionnaire survey

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

2019 Chinese expert consensus statement on diagnosis and treatment of syphilis

引用

Chinese Medical Journal 2020年第19期133卷 2335-2337页

作者：无 Qian-Qiu Wang Rui-Li Zhang Yue-Ping Yin Quan-Zhong Liu Shu-Zhen Qi Dong-Mei Xu Yu-Ye Li Xiao-Fang Li Xiao-Hong Su Min-Zhi Wu Xian-Biao Zou Li-Gang Yang Xiang-Sheng Chen Ping-Yu Zhou Jin-Hua Xu Xiang-Dong Gong Guo-Jun Liang Juan Jiang Hao Cheng Feng-Qin Ge National center for Sexually Transmitted Disease Control China Centers for Disease Control and Prevention Committee of Sexually Transmitted Disease Branch of DermatovenereologyChinese Medical Association Committee of Sexually Transmitted Disease Branch of DermatologistsChinese Medical Doctor Association Institute of Dermatology Chinese Academy of Medical Science&Peking Union Medical CollegeNational Center for Sexually Transmitted Disease ControlChina Centers for Disease Control and PreventionNanjingJiangsu 210042China Department of Dermatology The Second Affiliated Hospital of Nanjing Medical UniversityNanjingJiangsu 210011China Department of Dermatology General Hospital of Tianjin Medical UniversityTianjin 300052China Department of Neurology Beijing Ditan HospitalCapital Medical UniversityBeijing 100015China Department of Dermatology The First Affiliated Hospital of Kunming Medical UniversityKunmingYunnan 650032China Department of Dermatology The 5th People’s Hospital of SuzhouSuzhouJiangsu 215131China Department of Dermatology The First Affiliated Hospital of General Hospital of People’s Liberation ArmyBeijing 100037China Department of Dermatology Dermatology Hospital of Southern Medical UniversityGuangzhouGuangdong 510091China Department of Sexually Transmitted Disease Institute Shanghai Skin Disease HospitalShanghai 200071China Department of Dermatology Huashan Hospital of Fudan UniversityShanghai 200040China Department of Dermatology Sir Run Run Shaw Hospital of Zhejiang University School of MedicineHangzhouZhejiang 310016China

Syphilis,caused by Treponema pallidum subsp pallidum(***),is a chronic,systemic human disease transmitted through sexual *** incidence and prevalence of syphilis is still high in china.[1]To guide the prevention measures and management of this disease,we renew the guidelines on diagnosis and treatment of syphilis[Supplementary file,http://***/CM9/A292].Manifestations and diagnosis of all stages of syphilis are presented in Table 1,and management in Table 2.

关键词： diagnosis prevention treatment

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

非小细胞肺癌分子病理检测临床实践指南(2021版)

引用

中华病理学杂志 2021年第4期50卷 323-332页

作者：中华医学会病理学分会国家病理质控中心中华医学会肿瘤学分会肺癌学组中国抗癌协会肺癌专业委员会中国胸部肿瘤研究协作组应建明师晓华梁智勇吴一龙陆舜不详国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院病理科 100021 中国医学科学院北京协和医学院北京协和医院病理科 100730 中国医学科学院北京协和医学院北京协和医院病理科10073. 广东省人民医院广东省肺癌研究所广州510080 上海市胸科医院上海交通大学附属胸科医院肿瘤科 200030

近十年来,晚期非小细胞肺癌的治疗,尤其是靶向治疗,取得了极大的进展,分子分型是非小细胞肺癌实施靶向治疗的前提。选择准确、快速、恰当的检测方法,全面筛选出适用靶向药物的目标人群具有重要临床意义。本指南基于国内临床实践数据及... 详细信息

近十年来,晚期非小细胞肺癌的治疗,尤其是靶向治疗,取得了极大的进展,分子分型是非小细胞肺癌实施靶向治疗的前提。选择准确、快速、恰当的检测方法,全面筛选出适用靶向药物的目标人群具有重要临床意义。本指南基于国内临床实践数据及结合中国国情,以国内已上市治疗药物及体外诊断检测试剂为导向制定,重在对分子病理检测实践的指导。其他靶基因及免疫治疗相关生物标志物只做简单概述,待更多实践数据的积累后更新。

关键词：体外诊断临床实践指南非小细胞肺癌目标人群分子病理检测靶向治疗免疫治疗靶向药物

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

非小细胞肺癌MET临床检测中国专家共识

引用

中华病理学杂志 2022年第11期51卷 1094-1103页

作者：中华医学会病理学分会国家病理质控中心中华医学会肿瘤学分会肺癌学组中国抗癌协会肺癌专业委员会中国胸部肿瘤研究协作组周晓燕梁智勇陆舜吴一龙不详复旦大学附属肿瘤医院病理科上海200032 中国医学科学院北京协和医学院北京协和医院病理科北京100730 上海交通大学附属胸科医院肿瘤科上海200030 广东省人民医院广东省肺癌研究所广州510080

非小细胞肺癌(non-small cell lung cancer,NSCLC)中MET异常(MET alteration)包括MET基因第14号外显子跳跃突变(MET 14跳突)、MET基因扩增、MET基因点突变(主要是激酶区突变)、MET基因融合及MET蛋白过表达等。NSCLC患者中MET 14跳突的... 详细信息

非小细胞肺癌(non-small cell lung cancer,NSCLC)中MET异常(MET alteration)包括MET基因第14号外显子跳跃突变(MET 14跳突)、MET基因扩增、MET基因点突变(主要是激酶区突变)、MET基因融合及MET蛋白过表达等。NSCLC患者中MET 14跳突的发生率为0.9%~4.0%,目前国内外已有针对MET 14跳突的靶向药物获批上市,晚期NSCLC患者应进行包含MET 14跳突的检测以筛选MET抑制剂靶向治疗获益人群;原发MET基因扩增在NSCLC患者中的发生率为1%~5%,继发MET基因扩增在表皮生长因子受体酪氨酸激酶抑制剂(tyrosine kinase inhibitor,TKI)耐药患者中发生率为5%~50%,在间变性淋巴瘤激酶TKI耐药患者中发生率约为13.;MET蛋白过表达在NSCLC患者的发生率为13.7%~63.7%。关于MET基因扩增和MET蛋白过表达的多项临床试验正在进行中,显示出其在MET抑制剂临床治疗中作为生物标志物具有重要指导价值。准确检测MET异常是实施MET抑制剂治疗的前提,因MET异常形式和检测方法多,临床检测中面临的问题和挑战多,故需进一步梳理和规范。本编写组结合临床实践经验、文献阅读并组织专家讨论,针对MET异常的3.主要类型(MET 14跳突、MET基因扩增和MET蛋白过表达)制定了本共识,以期指导临床MET检测的实践。

关键词：间变性淋巴瘤激酶非小细胞肺癌基因扩增临床试验临床检测靶向治疗文献阅读基因融合

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

中国人群肝癌筛查指南(2022,北京)

引用

中华肿瘤杂志 2022年第8期44卷 779-814页

作者：赫捷陈万青沈洪兵李霓曲春枫石菊芳孙凤姜晶曹广文庄贵华彭绩中国人群肝癌筛查指南制定专家组中国人群肝癌筛查指南制定工作组国家癌症中心国家肿瘤临床医学研究中心中国医学科学院北京协和医学院肿瘤医院北京100021 南京医科大学公共卫生学院肿瘤个体化医学省部共建协同创新中心南京211166 北京大学公共卫生学院北京100191 吉林大学第一医院长春130021 海军军医大学流行病学教研室上海200433 西安交通大学医学部公共卫生学院西安710061 深圳市慢性病防治中心深圳518020 不详

中国人群的肝癌存在生存率低、死亡率高的情况,如何有效降低肝癌相关负担仍是中国公共卫生和慢性病防控领域亟待解决的重大问题,而肝癌人群筛查策略优化是值得持续探索的重要抓手和方向。中国人群肝癌筛查指南受国家卫生健康委员会疾病... 详细信息

中国人群的肝癌存在生存率低、死亡率高的情况,如何有效降低肝癌相关负担仍是中国公共卫生和慢性病防控领域亟待解决的重大问题,而肝癌人群筛查策略优化是值得持续探索的重要抓手和方向。中国人群肝癌筛查指南受国家卫生健康委员会疾病预防控制局委托,由国家癌症中心发起,联合多学科专家,根据世界卫生组织推荐的指南制定原则和方法,整合肝癌人群筛查领域的国内外研究新证据,兼顾中国国情及实践经验,针对肝癌筛查过程中的筛查人群、筛查技术、监测方案等呈现循证推荐,以期为中国人群肝癌筛查实践的规范提供参考。

关键词：肝肿瘤筛查监测指南中国

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：